Cite
HARVARD Citation
Imlay, H. et al. (2021). Examining valganciclovir prophylaxis duration among high‐risk donor seropositive/recipient seronegative heart transplant recipients in a larger cohort. Transplant infectious disease. 23 (4), p. n/a. [Online].